penicillin v has been researched along with cefpodoxime proxetil in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chavanet, P; Gouyon, JB; Guetat, F; Portier, H | 1 |
Chavanet, P; Grey, PC; Ichou, F; Kisterman, JP; Portier, H; Safran, C; Waldner-Combernoux, A | 1 |
Dajani, AS; Kessler, SL; Mendelson, R; Todd, WM; Uden, DL | 1 |
Fiessinger, S; Gehanno, P; Ichou, F; Pelc, A; Portier, H | 1 |
4 trial(s) available for penicillin v and cefpodoxime proxetil
Article | Year |
---|---|
Five day treatment of pharyngotonsillitis with cefpodoxime proxetil.
Topics: Adolescent; Adult; Cefpodoxime Proxetil; Ceftizoxime; Cefuroxime; Female; Humans; Male; Middle Aged; Penicillin V; Pharyngitis; Pilot Projects; Prodrugs; Streptococcus pyogenes; Tonsillitis | 1990 |
Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefpodoxime Proxetil; Ceftizoxime; Child; Drug Administration Schedule; Female; France; Humans; Male; Middle Aged; Penicillin V; Pharyngitis; Prodrugs; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1994 |
Cefpodoxime proxetil vs. penicillin V in pediatric streptococcal pharyngitis/tonsillitis.
Topics: Adolescent; Cefpodoxime Proxetil; Ceftizoxime; Child; Child, Preschool; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Penicillin V; Pharyngitis; Single-Blind Method; Statistics as Topic; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis; Treatment Outcome | 1993 |
Cost saving of 5-day therapy with cefpodoxime proxetil versus standard 10-day beta-lactam therapy for recurrent pharyngotonsillitis in adults. A prospective general practice study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cefpodoxime Proxetil; Ceftizoxime; Clavulanic Acid; Clavulanic Acids; Cost-Benefit Analysis; Drug Therapy, Combination; Family Practice; France; Humans; Penicillin V; Pharyngitis; Prodrugs; Recurrence; Tonsillitis; Treatment Outcome | 1996 |